Gonal-F (Follitropin alfa)

DRUG2 trials

Sponsors

Merck KGaA, Darmstadt, Germany, Ferring Pharmaceuticals

Conditions

InfertilityMultifollicular Stimulation

Phase 3

A Trial to Compare the Ovarian Response of REKOVELLE and GONAL-F in Conventional Dosing in Women Undergoing Controlled Ovarian Stimulation

CompletedNCT05263388

Ferring PharmaceuticalsInfertility

Start: 2022-07-15End: 2024-04-16Updated: 2025-04-02

Unknown Phase

An Observational Study of Gonal-F Filled by Mass Pens in Multifollicular Stimulation Prior to In-vitro Fertilization (IVF) or Intracytoplasmic Sperm Injection (ICSI)

CompletedNCT01075854

Merck KGaA, Darmstadt, GermanyMultifollicular Stimulation

Start: 2009-04-30End: 2010-03-31Updated: 2014-07-31

Related Papers

Ovarian stimulation with follitropin delta for <i>in vitro</i> fertilization: a multicentre, randomized, assessor-blind comparison with follitropin alfa using conventional dosing regimens (ADAPT-1 trial)

Human Reproduction2025-06-12